Clincosm LogoSign in Get a demo

Arabic Version Of Henry Ford Hospital Headache Disability Inventory Questionnaire : Validity, And Reliability

Sponsor
Cairo University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06125821
Collaborator
(none)
250
Enrollment
11
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

ARABIC VERSION OF HENRY FORD HOSPITAL HEADACHE DISABILITY INVENTORY QUESTIONNAIRE:

CROSS-CULTURAL ADAPTATION, VALIDITY, AND RELIABILITY

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This questionnaire will be developed to assess the impact of headache on functional and emotional aspects of daily life. The Alpha version of HDI (alpha-HDI) included 40 items, but the newest Beta version (beta-HDI) contains 25 items. The Beta version of HDI, developed by Jacobson (1994) in English, is a generic headache disability questionnaire widely administered in the related research studies.

    This questionnaire measures the effect of different medical and rehabilitation treatments on the physical and emotional disabilities in patients with different types of headaches. This generic headache questionnaire is not specific to any headache type. Therefore, HDI will be applied to follow the general consequences of different headache types and to compare different aspects of disability for a variety of headaches. Based on the literature, the original HDI has strong internal consistency/reliability and construct validity. The results of test-retest showed that HDI has an acceptable level of reliability considering the total questionnaire and its subscale scores.

    The validity and reliability of the non-English versions of HDI, such as Spanish, have been previously investigated and confirmed. The Arabic researchers and practitioners need valid and reliable tools to measure the emotional and functional states of patients with different headache disorders.

    So, This study will be carried out to translate and culturally adapt the HDI questionnaire for administration among the Egyptian patients with headaches. Moreover, This study will assess the validity and reliability of the developed Arabic version of this questionnaire. Creation of questionnaires in different languages must pass through many steps. Questionnaires must be translated, then culturally adapted to the environment in which they will be used.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    250 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Cross-Sectional
    Official Title:
    Arabic Version Of Henry Ford Hospital Headache Disability Inventory Questionnaire : Cross Cultural Adaptation, Validity, And Reliability
    Anticipated Study Start Date :
    Dec 1, 2023
    Anticipated Primary Completion Date :
    Oct 1, 2024
    Anticipated Study Completion Date :
    Nov 1, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    questionnaire

    ARABIC VERSION OF HENRY FORD HOSPITAL HEADACHE DISABILITY INVENTORY QUESTIONNAIRE: CROSS-CULTURAL ADAPTATION, VALIDITY, AND RELIABILITY

    Outcome Measures

    Primary Outcome Measures

    1. Arabic Version Of Henry Ford Hospital Headache Disability Inventory Questionnaire : Cross Cultural Adaptation, Validity, And Reliability [4 month]

      This study will be carried out to translate and culturally adapt the Henry ford inventory questionnaire for administration among the Egyptian patients with headaches.

    2. Arabic Version Of Henry Ford Hospital Headache Disability Inventory Questionnaire : Cross Cultural Adaptation, Validity, And Reliability [4 month]

      This study will assess the validity and reliability of the developed Arabic version of this questionnaire.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    1. Chronic primary headache to enter the study.

    2. Patients having chronic daily headaches at least 15 days a month.

    Exclusion Criteria:

    1. Patients with secondary headaches who has underlying serious problems (infection, trauma, tumors, and brain bleedings)

    2. Severe psychotic and mental dysfunctions

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Cairo University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Samah Ali Mohamed Abd Alghani, principal investigator, Cairo University
    ClinicalTrials.gov Identifier:
    NCT06125821
    Other Study ID Numbers:
    • Arabic Version questionnaire
    First Posted:
    Nov 9, 2023
    Last Update Posted:
    Nov 9, 2023
    Last Verified:
    Nov 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Headache

    Study Results

    No Results Posted as of Nov 9, 2023